Drug Delivery: Fundamentals and Beyond

Who Should Attend?
The course will be of value to those new to this field or those working in specific sectors of pharma, biotech and related industries (e.g. nutraceuticals, cosmetics) that want to learn a broader perspective of drug delivery technologies. This would include:
  • R&D Scientists and Managers 
  • Chemists 
  • Engineers 
  • Business Development 
  • Technology Transfer Managers 
  • Investors 
  • Intellectual Property Managers 
  • Biotechnologists 
  • Regulatory Affairs Personnel 

Professionals in start-ups, drug discovery and early drug development companies will benefit along with technical and business staff that serve in CROs and CMOs. 

Dr. Pierandrea Esposito is Cofounder and Associate Director at SiTec PharmaBio, a company focused on the development of innovative technologies for drug delivery, based on dense-CO2 processing. He has 25 years experience in pharmaceutical and biotech industry, and held several director or management positions at Esteve, SiTec Consulting, Critical Pharmaceuticals Ltd, Serono, and Vectopharma. He has experience in pharmaceutical development, of drug products based on delivery systems, advanced formulations, and conjugation technologies. His interests focus in micro and nanoparticles, biomolecules delivery, in drug solubilization/ absorption of small molecules for oral and transmucosal routes, in physical pharmacy. Dr. Esposito graduated in Pharmaceutical Chemistry and Technology, University of Trieste, (Italy). He has been visiting scientist at College of Pharmacy, University of Kentucky (USA). He coauthored 22 publications (research articles, reviews, book chapters), and 45 abstracts; he is a coinventor in 16 patents, and a member of Scientific Editorial Boards of several international journals. 

Dr. Hana Danan is Cofounder and Director at SiTec PharmaBio. She has a Ph.D. in Pharmaceutics and Pharmaceutical Analysis from University of Kentucky (US), a B.Sc. in Pharmacy from Damascus University (Syria) and 25 years of experience in pharmaceutical product development. She held positions at Sola Barnes-Hind and Parke-Davis/Warner Lambert in the US and later she established her own consulting company in Europe, before founding SiTec PharmaBio. Dr. Danan has acquired a wide range of experience in formulation and analytical development, working on oral, semi-solid and solid dosage forms. She has also established FDA compliant quality systems in research laboratories, and supported companies seeking CEP certification from EDQM.